Recombinant FLT1 (Icrucumab Biosimilar) antibody (PE)
The PE-conjugated Human Monoclonal anti-FLT1 (Icrucumab Biosimilar) antibody (ABIN7867267) specifically detects FLT1 (Icrucumab Biosimilar) in FACS.
The antibody is reactive with Human samples.
Catalog No. ABIN7867267
$569.23
Plus shipping costs $50.00
100 tests
Shipping to:
United States
Delivery in 2 to 4 Business Days
Quick Overview for Recombinant FLT1 (Icrucumab Biosimilar) antibody (PE) (ABIN7867267)
Target
FLT1 (Icrucumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This FLT1 (Icrucumab Biosimilar) antibody is conjugated to PE
Application
Flow Cytometry (FACS)
-
-
Purpose
- PE-conjugated Anti-FLT1(icrucumab biosimilar) mAb
-
Isotype
- IgG1
-
-
anti-FLT1 (Icrucumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- Flow Cyt 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2°C-8°C for 6 months
-
Expiry Date
- 6 months
-
-
- FLT1 (Icrucumab Biosimilar)
-
Alternative Name
- icrucumab biosimilar
-
Target Type
- Biosimilar
-
Background
-
Synonyms: FLT,FLT-1,VEGFR-1,VEGFR1,18F1, IMC-18F1, LY3012212
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- P17948
Target
-
You are here:
